Sell side looks sickening at the moment. Timelines have been blown out ridiculously and now moving forward we can only hope an ilumen deal is struck that actually produces a meaningful revenue figure. It’s going to need something special to put a spark in the share price. It always makes me wonder how a SPP can be heavily oversubscribed yet there is a heap on offer at a less price and nobody wants to touch it
Ann: Medibio Quarterly Update and Cashflow Report, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TRI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.24M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.5¢ | 2.5¢ | $16.53K | 661.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 2314300 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 190000 | 1 |
View Market Depth
| Last trade - 15.42pm 20/06/2024 (20 minute delay) ? |
| TRI (ASX) Chart |